Fabrication of BSA Loaded Poly (Caprolactone) (PCL)/Hydroxyapatite (HA) Composite Microsphere for Tissue Engineering Application

Article Preview

Abstract:

In this study, PCL microsphere has been synthesised using the double emulsion technique and a freeze dry technique. Bovine Serum Albumin (BSA) was added as a model protein and Hydroxyapatite (HA) to enhance osteoconductivity properties of the microsphere. Poly (caprolactone) (PCL)-based microspheres were synthesized and characterized. Microspheres were produced with 5%, 10%, and 15% (w/v) PCL solution (30mL) by dissolving different amounts of PCL in dichloromethane (DCM). Microspheres produced from 5% (w/v) PCL concentration had an average diameter of 100 – 120 μm. Bovine serum albumin (BSA) (0.04% w/v) and 10% w/w of HA powder were added into the microspheres produced from 5% (w/v) PCL concentration. The microsphere was then characterized using different techniques and in vitro release study of BSA was conducted. Prepared microsphere showed good potential for bone tissue engineering.

You might also be interested in these eBooks

Info:

Periodical:

Advanced Materials Research (Volumes 1030-1032)

Pages:

82-85

Citation:

Online since:

September 2014

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2014 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

* - Corresponding Author

[1] X.M. Peter and E. Jennifer, Scaffolding in Tissue Engineering, Taylor & Francis Group, Boca Raton, London, NY (2006), CRC press.

Google Scholar

[2] T. Sun, T. H. Khan, and N. Sultana: Fabrication and In Vitro Evaluation of Nanosized Hydroxyapatite/Chitosan-Based Tissue Engineering Scaffolds.  J Nanomater, vol. 2014, Article ID 194680, 8 pages, 2014. doi: 10. 1155/2014/194680.

DOI: 10.1155/2014/194680

Google Scholar

[3] N. Sultana and T. H. Khan: Factorial Study of Compressive Mechanical Properties and Primary In Vitro Osteoblast Response of PHBV/PLLA Scaffolds. J Nanomater, vol. 2012, Article ID 656914, 8 pages, 2012. doi: 10. 1155/2012/656914.

DOI: 10.1155/2012/656914

Google Scholar

[4] V. Coccoli, A. Luciani, S. Orsi, V. Guarino, F. Causa and P.A. Netti: Engineering of poly(epsilon-caprolactone) microcarriers to modulate protein encapsulation capability and release kinetic. J. Mater. Sci. Mater. Med. Vol. 19 (2008), p.1703–1711.

DOI: 10.1007/s10856-007-3253-9

Google Scholar

[5] M.A. Woodruff and D.W. Hutmacher: The return of a forgotten polymer—Polycaprolactone in the 21st century. Prog. Polym. Sci. Vol. 35 (2010), p.1217–1256.

DOI: 10.1016/j.progpolymsci.2010.04.002

Google Scholar

[6] S. Freitas, H.P. Merkle and B. Gander: Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J. Control. Release Vol. 102 (2005), p.313–32.

DOI: 10.1016/j.jconrel.2004.10.015

Google Scholar

[7] F. Franks: Freeze-drying of bioproducts: putting principles into practice. Eur. J. Pharm. Biopharm. Vol. 45 (2008), p.221–229.

Google Scholar

[8] A. Rezaei and M.R. Mohammadi: In vitro study of hydroxyapatite/polycaprolactone (HA/PCL) nanocomposite synthesized by an in situ sol–gel process. Mat. Sci. Eng.: C Vol. 33 (2013), p.390–396.

DOI: 10.1016/j.msec.2012.09.004

Google Scholar

[9] S.C. Neves, L.S.M. Teixaira, L. Moroni, R.L. Reis, C.A.V. Blitterswijk, N.M. Alves, M. Karperien and J.F. Mano: Chitosan/poly(ε-caprolactone) blends scaffolds for cartilage repair. Biomat Vol. 32 (2001), pp.1068-1079.

DOI: 10.1016/j.biomaterials.2010.09.073

Google Scholar